{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T15:27:25Z","timestamp":1793201245109,"version":"4.5.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.diagmicrobio.2018.02.013","type":"journal-article","created":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T07:49:40Z","timestamp":1519372180000},"page":"226-228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Point-of-care testing for CXCL13 in Lyme neuroborreliosis"],"prefix":"10.1016","volume":"91","author":[{"given":"Annukka","family":"Pietik\u00e4inen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarmo","family":"Oksi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jukka","family":"Hyt\u00f6nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2018.02.013_bb0005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2377-13-2","article-title":"Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection","volume":"13","author":"Bremell","year":"2013","journal-title":"BMC Neurol"},{"key":"10.1016\/j.diagmicrobio.2018.02.013_bb0010","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1212\/WNL.43.1_Part_1.169","article-title":"Borrelia burgdorferi\u2013specific intrathecal antibody production in neuroborreliosis: a follow-up study","volume":"43","author":"Hammers-Berggren","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.diagmicrobio.2018.02.013_bb0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1742-2094-11-103","article-title":"CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation","volume":"11","author":"Hyt\u00f6nen","year":"2014","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.diagmicrobio.2018.02.013_bb0020","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/cid\/cix568","article-title":"Characteristics and clinical outcome of Lyme neuroborreliosis in a high endemic area, 1995\u20132014: a retrospective cohort study in Denmark","volume":"65","author":"Knudtzen","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2018.02.013_bb0025","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nrneurol.2015.121","article-title":"Lyme neuroborreliosis\u2014epidemiology, diagnosis and management","volume":"11","author":"Koedel","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.diagmicrobio.2018.02.013_bb0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/QCO.0000000000000332","article-title":"Lyme neuroborreliosis","volume":"30","author":"Koedel","year":"2017","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2018.02.013_bb0035","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s00415-008-0785-y","article-title":"CSF B-lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis","volume":"255","author":"Lj\u00f8stad","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/j.diagmicrobio.2018.02.013_bb0040","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1468-1331.2009.02862.x","article-title":"EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis","volume":"17","author":"Mygland","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.diagmicrobio.2018.02.013_bb0045","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12974-017-0948-9","article-title":"Cerebrospinal fluid CXCL13 as a diagnostic marker of neuroborreliosis in children: a retrospective case\u2013control study","volume":"14","author":"Remy","year":"2017","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.diagmicrobio.2018.02.013_bb0050","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1212\/WNL.0b013e318211c39a","article-title":"A prospective study on the role of CXCL13 in Lyme neuroborreliosis","volume":"76","author":"Schmidt","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.diagmicrobio.2018.02.013_bb0055","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/jnnp.2009.195438","article-title":"The chemokine CXCL13 in acute neuroborreliosis","volume":"81","author":"Senel","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.diagmicrobio.2018.02.013_bb0060","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3109\/00365548.2013.776700","article-title":"Cerebrospinal fluid chemokine CXCL13 in the diagnosis of neuroborreliosis in children","volume":"45","author":"Sillanp\u00e4\u00e4","year":"2013","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2018.02.013_bb0065","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(11)60103-7","article-title":"Lyme borreliosis","volume":"379","author":"Stanek","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.diagmicrobio.2018.02.013_bb0070","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1128\/JCM.00084-11","article-title":"Discriminating Lyme neuroborreliosis from other neuroinflammatory diseases by levels of CXCL13 in cerebrospinal fluid","volume":"49","author":"van Burgel","year":"2011","journal-title":"J Clin Microbiol"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889318300725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889318300725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T15:40:08Z","timestamp":1603899608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889318300725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0732889318300725"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2018.02.013","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Point-of-care testing for CXCL13 in Lyme neuroborreliosis","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2018.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}